Is CellaVision AB (publ) (CLVSF) a Buy, Sell, or Hold?
OTC : CLVSF
CellaVision AB (publ)
$14 USD
$0 (0.0%)
- Volume
- 400
- Average Volume
- 35
- Market Capitalization
- $333.92M
- P/E Ratio
- 25.69
- Dividend Yield
- 1.98%
- Price Target
- Year High
- $19.28
- Year Low
- $13.49
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.51
- Current Ratio
- $3.31
Company Overview
OTC
Steve Ferguson
Medical - Devices
Healthcare
CLVSF
241
SE
USD
Liquidity Metrics
0.06
3.31
2.33
1.30
0.51
Sales & Valuation
$758.97M
4.49
3.74
29.51
4.71
Profitability
$6.42
$153.08M
17.46%
22.10%
14.59%
11.30%
P/E Metrics
25.69
-1.75
-1.75
Analyst Price Target & Rating
4/5
1 Analysts
%
Financial Health Scores
9.10
6/9
$302.51M
$1.13B
$254.06M
$164.46M
Key Metrics (TTM)
$3.25B
4.39
15.60
3.31
14.59%
12.66%
3.83%
3.34%
$67.25
217 days
Company Executives
| Name | Title |
|---|---|
| Lisa Bodily Nordqvist | Corporate Communications & Investor Relations |
| Simon Ostergaard | Chief Executive Officer & President |
| Steve Ferguson | Chief Executive Officer |
| Urban Strindlov | Vice President of Global Sales |
| Christer Fahraeus | Founder & Director |
| Helena Raihle | Corporate Communications & Investor Relations |
| Julien Veyssy | Vice President of Operations |
| Peter Wilson | Vice President of Business Development & Global Marketing |
| Anne Safstrom Lanner | Vice President of Human Resources |
| Monica Jonsson | Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About CellaVision AB (publ) (OTC:CLVSF) Stock
CellaVision AB (publ), a company established in Lund, Sweden, in 1994, specializes in the development and distribution of digital analytical solutions for blood and body fluid samples. Their offerings cater to the healthcare services sector, with a significant global presence spanning Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific region. The company's product portfolio includes advanced hardware such as the CellaVision DM1200 and CellaVision DM9600, which are designed to automatically capture digital images from blood smears and various body fluid preparations, alongside the CellaVision DC-1 analyzer. Complementing their instrumentation is a suite of specialized software applications. For instance, the CellaVision Peripheral Blood Application streamlines and s ... tandardizes the morphological examination of peripheral blood smears for laboratory professionals. Similarly, the CellaVision Advanced RBC Application facilitates a comprehensive evaluation of red blood cell morphology, while the CellaVision Body Fluid Application offers automated and standardized analysis for body fluid preparations. To enhance collaboration and flexibility, the CellaVision Remote Review Software eliminates geographical barriers in the smear review process. Further enriching their ecosystem are tools such as the CellaVision Server Software, which unifies workflows across single or multiple testing sites, and the CellaVision Dashboard, providing instant insights into analyzer and reviewer performance metrics. For staff development, the cloud-based CellaVision Proficiency Software aids laboratory managers in assessing and enhancing team competency in cell morphology. Educational resources include CellaVision CellAtlas, combining mini-lectures with an extensive cell image database. Finally, CellaVision VET extends their digital microscopy solutions to the field of veterinary hematology. Their clientele primarily consists of hospital and commercial diagnostic laboratories.
CellaVision AB (publ) (CLVSF) Q2 2026 Earnings Call Transcript
2026-07-17 07:16:36
CellaVision AB (publ) (CLVSF) Q2 2026 Earnings Call Transcript
Frequently Asked Questions
-
What is the current CellaVision AB (publ) (CLVSF) stock price?
-
CellaVision AB (publ)(OTC:CLVSF) stock price is $14 in the last trading session. During the trading session, CLVSF stock reached the peak price of $19.2796 while $13.49 was the lowest point it dropped to. The percentage change in CLVSF stock occurred in the recent session was 0.0% while the dollar amount for the price change in CLVSF stock was $0.
-
CLVSF's industry and sector of operation?
-
The OTC listed CLVSF is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of CLVSF?
-
Lisa Bodily Nordqvist | Corporate Communications & Investor Relations
Simon Ostergaard | Chief Executive Officer & President
Steve Ferguson | Chief Executive Officer
Urban Strindlov | Vice President of Global Sales
Christer Fahraeus | Founder & Director -
How many employees does CLVSF have?
-
Number of CLVSF employees currently stands at 241. CLVSF operates from Mobilvägen 12, Lund, SN 223 62, SE.
-
Link for CLVSF official website?
-
Official Website of CLVSF is: https://www.cellavision.com
-
How do I contact CLVSF?
-
CLVSF could be contacted at phone #46 4 64 60 16 00 and can also be accessed through its website. CLVSF operates from Mobilvägen 12, Lund, SN 223 62, SE.
-
How many shares of CLVSF are traded daily?
-
The average number of CLVSF shares traded daily for last 3 months was 35.
-
What is the market cap of CLVSF currently?
-
The market value of CLVSF currently stands at $333.92M with its latest stock price at $14